FONDAPARINUX SODIUM
NDC 55150-231, FONDAPARINUX SODIUM, injection, solution, from Eugia US LLC.
- Product NDC
- 55150-231
- Status
- Listed
- Labeler
- Eugia US LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206918
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55150-231 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FONDAPARINUX SODIUM5 mg/.4mL
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55150-231-02 | 55150023102 | 2 SYRINGE, GLASS in 1 CARTON (55150-231-02) / .4 mL in 1 SYRINGE, GLASS (55150-231-00) |
| 55150-231-10 | 55150023110 | 10 SYRINGE, GLASS in 1 CARTON (55150-231-10) / .4 mL in 1 SYRINGE, GLASS (55150-231-00) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8ea61d0d-4403-4d9f-a946-85a459cc0aa0Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55150-231
Use it
Look up 55150-231 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55150-231 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55150-231. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.